Werewolf Therapeutics Inc

HOWLNASDAQ · USD
0.96USD0.00 (-2.16%)
4510

Werewolf Therapeutics Inc (HOWL) Option Chain

As of September 24, 2026, Werewolf Therapeutics Inc is trading at $0.96, a -2.16% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 181.7%. IV Rank is 38%.

Read more

Tracking the HOWL option chain helps you see every strike and expiry on Werewolf Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Werewolf Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of HOWL options activity at a glance. Use our scanner to monitor the HOWL option chain in real time and filter for the HOWL options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For HOWL stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the HOWL option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where HOWL stock options are being actively traded and where they are not.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma.

The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Werewolf Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen HOWL options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of HOWL stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile28.17% Subdued
  • Market cap (M$)47
  • 52 weeks high-59.66%
  • 52 weeks low255.56%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$4.00
    316.67% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-03
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.74
  • EPS growth next 5 years—

As of September 24, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
24.584220.170.460.500.750.50-48.98—0.300.000.300075.42
63.9913000.200.00—0.201.00+2.04—0.450.040.410136.01
83.40000.100.00—0.101.50+53.060.250.800.54-0.020016.60
91.99000.400.00—0.402.00+104.080.751.251.04-0.04008.01
95.923,50000.050.00—0.052.50+155.101.251.801.54-0.020214.08

As of September 24, 2026

Scan the full option chain in one place

Browse the full HOWL option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial